Other

Novartis to buy back $5 bn in shares

Swiss pharmaceutical giant Novartis announced Wednesday a $5.0 billion share buyback even though competition from generics ate away at sales and earnings last year.

Other

GSK sees earnings rise amid good demand for vaccines

Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.

Health

Fragranced products: Risks for people and profits?

A University of Melbourne researcher has found that over one-third of Americans report health problems—from asthma attacks to migraine headaches—when exposed to common fragranced consumer products such as air fresheners, ...

Health

An angel on my shoulder: Mobile telemedicine for nursing homes

In June 2016, Zeriscope, a technology company based in Charleston, SC, reached an agreement with White Oak Management (WOM) of Spartanburg, SC to provide its mobile telemedicine platform to more than a dozen of its skilled ...

Health

Nonprofit hospitals earn substantial profits

Seven of the 10 most profitable hospitals in the United States in 2013 - each earning more than $163 million in profits from patient care services—were nonprofit hospitals, according to new research from the Johns Hopkins ...

Health

Alternative payment models can help improve patient care

(HealthDay)—Alternative payment models (APMs) have been and are being developed that can allow physicians to offer new and improved services to their patients, according to a report published by the American Medical Association ...

page 4 from 11